Xue et al confirmed its association with NAFLD and liver fibrosis risk.[31] Ye et al identified the TyG index as a diagnostic biomarker for NAFLD, enhanced when combined with ALT.[32] Wang et al’s meta-analysis affirmed the TyG index’s diagnostic and predictive utility for NAFLD.[33]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.